Advanced
loginLogin My account Interest product Order status Cart
 
Support
   
 
  Choose your location
 
   
 
Integrated Solutions & Services
 
100% Guarantee_July
 
ISO
 
Home > Support > Publications
  Publications
  Publication Search
  Total : 36036 publications.
   New Feature : Get publication update automatically by subscribing a free reader RSS Feed
Catalog # Product Name Authors Journal Name Article Title
H00005295-M01 PIK3R1 monoclonal antibody (M01), clone 3A10 Liu CH, Chen TC, Chau GY, Jan YH, Chen CH, Hsu CN, Lin KT, Juang YL, Lu PJ, Cheng HC, Chen MH, Chang CF, Ting YS, Kao CY, Hsiao M, Huang CY. Mol Cell Proteomics. 2013 Feb 8. [Epub ahead of print] An analysis of protein-protein interactions in cross-talk pathways reveals CRKL as a novel prognostic marker in hepatocellular carcinoma.
PAB18088 YWHAZ polyclonal antibody Liu CH, Chen TC, Chau GY, Jan YH, Chen CH, Hsu CN, Lin KT, Juang YL, Lu PJ, Cheng HC, Chen MH, Chang CF, Ting YS, Kao CY, Hsiao M, Huang CY. Mol Cell Proteomics. 2013 Feb 8. [Epub ahead of print] An analysis of protein-protein interactions in cross-talk pathways reveals CRKL as a novel prognostic marker in hepatocellular carcinoma.
H00005170-B01P PDPK1 purified MaxPab mouse polyclonal antibody (B01P) Liu CH, Chen TC, Chau GY, Jan YH, Chen CH, Hsu CN, Lin KT, Juang YL, Lu PJ, Cheng HC, Chen MH, Chang CF, Ting YS, Kao CY, Hsiao M, Huang CY. Mol Cell Proteomics. 2013 Feb 8. [Epub ahead of print] An analysis of protein-protein interactions in cross-talk pathways reveals CRKL as a novel prognostic marker in hepatocellular carcinoma.
H00005335-M01 PLCG1 monoclonal antibody (M01), clone 2A2 Liu CH, Chen TC, Chau GY, Jan YH, Chen CH, Hsu CN, Lin KT, Juang YL, Lu PJ, Cheng HC, Chen MH, Chang CF, Ting YS, Kao CY, Hsiao M, Huang CY. Mol Cell Proteomics. 2013 Feb 8. [Epub ahead of print] An analysis of protein-protein interactions in cross-talk pathways reveals CRKL as a novel prognostic marker in hepatocellular carcinoma.
H00002534-D01P FYN purified MaxPab rabbit polyclonal antibody (D01P) Liu CH, Chen TC, Chau GY, Jan YH, Chen CH, Hsu CN, Lin KT, Juang YL, Lu PJ, Cheng HC, Chen MH, Chang CF, Ting YS, Kao CY, Hsiao M, Huang CY. Mol Cell Proteomics. 2013 Feb 8. [Epub ahead of print] An analysis of protein-protein interactions in cross-talk pathways reveals CRKL as a novel prognostic marker in hepatocellular carcinoma.
H00000891-D01P CCNB1 purified MaxPab rabbit polyclonal antibody (D01P) Liu CH, Chen TC, Chau GY, Jan YH, Chen CH, Hsu CN, Lin KT, Juang YL, Lu PJ, Cheng HC, Chen MH, Chang CF, Ting YS, Kao CY, Hsiao M, Huang CY. Mol Cell Proteomics. 2013 Feb 8. [Epub ahead of print] An analysis of protein-protein interactions in cross-talk pathways reveals CRKL as a novel prognostic marker in hepatocellular carcinoma.
PAB12647 KDR polyclonal antibody Liu CH, Chen TC, Chau GY, Jan YH, Chen CH, Hsu CN, Lin KT, Juang YL, Lu PJ, Cheng HC, Chen MH, Chang CF, Ting YS, Kao CY, Hsiao M, Huang CY. Mol Cell Proteomics. 2013 Feb 8. [Epub ahead of print] An analysis of protein-protein interactions in cross-talk pathways reveals CRKL as a novel prognostic marker in hepatocellular carcinoma.
H00003055-M02 HCK monoclonal antibody (M02), clone 2A6 Liu CH, Chen TC, Chau GY, Jan YH, Chen CH, Hsu CN, Lin KT, Juang YL, Lu PJ, Cheng HC, Chen MH, Chang CF, Ting YS, Kao CY, Hsiao M, Huang CY. Mol Cell Proteomics. 2013 Feb 8. [Epub ahead of print] An analysis of protein-protein interactions in cross-talk pathways reveals CRKL as a novel prognostic marker in hepatocellular carcinoma.
H00005781-B02P PTPN11 purified MaxPab mouse polyclonal antibody (B02P) Liu CH, Chen TC, Chau GY, Jan YH, Chen CH, Hsu CN, Lin KT, Juang YL, Lu PJ, Cheng HC, Chen MH, Chang CF, Ting YS, Kao CY, Hsiao M, Huang CY. Mol Cell Proteomics. 2013 Feb 8. [Epub ahead of print] An analysis of protein-protein interactions in cross-talk pathways reveals CRKL as a novel prognostic marker in hepatocellular carcinoma.
H00001399-M03 CRKL monoclonal antibody (M03), clone 4B5 Liu CH, Chen TC, Chau GY, Jan YH, Chen CH, Hsu CN, Lin KT, Juang YL, Lu PJ, Cheng HC, Chen MH, Chang CF, Ting YS, Kao CY, Hsiao M, Huang CY. Mol Cell Proteomics. 2013 Feb 8. [Epub ahead of print] An analysis of protein-protein interactions in cross-talk pathways reveals CRKL as a novel prognostic marker in hepatocellular carcinoma.
H00000572-M02 BAD monoclonal antibody (M02), clone 3H8 Liu CH, Chen TC, Chau GY, Jan YH, Chen CH, Hsu CN, Lin KT, Juang YL, Lu PJ, Cheng HC, Chen MH, Chang CF, Ting YS, Kao CY, Hsiao M, Huang CY. Mol Cell Proteomics. 2013 Feb 8. [Epub ahead of print] An analysis of protein-protein interactions in cross-talk pathways reveals CRKL as a novel prognostic marker in hepatocellular carcinoma.
H00000207-D01P AKT1 purified MaxPab rabbit polyclonal antibody (D01P) Liu CH, Chen TC, Chau GY, Jan YH, Chen CH, Hsu CN, Lin KT, Juang YL, Lu PJ, Cheng HC, Chen MH, Chang CF, Ting YS, Kao CY, Hsiao M, Huang CY. Mol Cell Proteomics. 2013 Feb 8. [Epub ahead of print] An analysis of protein-protein interactions in cross-talk pathways reveals CRKL as a novel prognostic marker in hepatocellular carcinoma.
H00003954-M03 LETM1 monoclonal antibody (M03), clone 6F7 Shin JY, Chung YS, Kang B, Jiang HL, Yu DY, Han K, Chae C, Moon JH, Jang G, Cho MH Cancer Gene Ther. 2013 Feb 8. doi: 10.1038/cgt.2013.6. Co-delivery of LETM1 and CTMP synergistically inhibits tumor growth in H-ras12V liver cancer model mice.
H00025855-M01 BRMS1 monoclonal antibody (M01), clone 2D4-2G11 Liu Y, Mayo MW, Nagji AS, Hall EH, Shock LS, Xiao A, Stelow EB, Jones DR Cancer Res. 2013 Feb 15;73(4):1308-17. doi: 10.1158/0008-5472.CAN-12-2489. Epub 2012 Dec 26. BRMS1 Suppresses Lung Cancer Metastases through an E3 Ligase Function on Histone Acetyltransferase p300.
H00003169-M01 FOXA1 monoclonal antibody (M01), clone 2D7 Kobayashi T, Iwaya K, Moriya T, Yamasaki T, Tsuda H, Yamamoto J, Matsubara O BMC Clin Pathol. 2013 Feb 6;13:5. doi: 10.1186/1472-6890-13-5. A simple immunohistochemical panel comprising 2 conventional markers, Ki67 and p53, is a powerful tool for predicting patient outcome in luminal-type breast cancer.
H00002810-M01 SFN monoclonal antibody (M01), clone 3C3 Sousa MM, Zub KA, Aas PA, Hanssen-Bauer A, Demirovic A, Sarno A, Tian E, Liabakk NB, Slupphaug G PLoS One. 2013;8(2):e55493. doi: 10.1371/journal.pone.0055493. Epub 2013 Feb 6. An inverse switch in DNA base excision and strand break repair contributes to melphalan resistance in multiple myeloma cells.
KA0970 Treponema pallidum Total ELISA Kit Arnaboldi PM, Seedarnee R, Sambir M, Callister SM, Imparato JA, Dattwyler RJ Clin Vaccine Immunol. 2013 Jan 30. An outer surface protein C (OspC) peptide derived from Borrelia burgdorferi sensu strico as a target for the serodiagnosis of early Lyme disease.
H00051567-B01P TTRAP purified MaxPab mouse polyclonal antibody (B01P) Thomson G, Watson A, Caldecott K, Denneny O, Depledge P, Hamilton N, Hopkins G, Jordan A, Morrow C, Raoof A, Waddell I, Ogilvie D Anal Biochem. 2013 Feb 12. pii: S0003-2697(13)00073-0. doi: 10.1016/j.ab.2013.02.001. Generation of assays and antibodies to facilitate the study of human 5'-tyrosyl DNA phosphodiesterase.
H00079047-B01P KCTD15 purified MaxPab mouse polyclonal antibody (B01P) Zarelli VE, Dawid IB Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2870-5. doi: 10.1073/pnas.1300203110. Epub 2013 Feb 4. Inhibition of neural crest formation by Kctd15 involves regulation of transcription factor AP-2.
PAB12351 PDE3B polyclonal antibody Uzawa K, Kasamatsu A, Baba T, Usukura K, Saito Y, Sakuma K, Iyoda M, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H. Cancer Medicine DOI: 10.1002/cam4.56 Targeting phosphodiesterase 3B enhances cisplatin sensitivity in human cancer cells.
< Prev12345678910Next >
Facebook Linkedin YouTube RSS
 
 
Terms & Conditions   |   Privacy Policy   |   Copyright and Trademark   
© 2013 Abnova Corporation. All rights reserved.
     
    If you have a question or comment, please select the topic you would like to contact.

Your message has been sent successfully!